Public Sector Pension Investment Board Increases Stock Holdings in Qiagen N.V. $QGEN

Public Sector Pension Investment Board raised its stake in shares of Qiagen N.V. (NYSE:QGEN - Free Report) by 5.2% in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 113,046 shares of the company's stock after buying an additional 5,593 shares during the quarter. Public Sector Pension Investment Board owned about 0.05% of Qiagen worth $4,478,000 at the end of the most recent reporting period.

A number of other hedge funds have also added to or reduced their stakes in the stock. Nuveen LLC purchased a new position in Qiagen during the 1st quarter valued at about $44,078,000. Invesco Ltd. boosted its position in shares of Qiagen by 13.5% during the 1st quarter. Invesco Ltd. now owns 449,638 shares of the company's stock valued at $18,053,000 after acquiring an additional 53,383 shares during the last quarter. Forsta AP Fonden boosted its position in shares of Qiagen by 185.8% during the 1st quarter. Forsta AP Fonden now owns 29,368 shares of the company's stock valued at $1,179,000 after acquiring an additional 19,093 shares during the last quarter. Citigroup Inc. boosted its position in shares of Qiagen by 51.4% during the 1st quarter. Citigroup Inc. now owns 473,388 shares of the company's stock valued at $18,754,000 after acquiring an additional 160,799 shares during the last quarter. Finally, Caisse Des Depots ET Consignations boosted its position in shares of Qiagen by 7.3% during the 1st quarter. Caisse Des Depots ET Consignations now owns 1,345,657 shares of the company's stock valued at $53,374,000 after acquiring an additional 91,357 shares during the last quarter. Hedge funds and other institutional investors own 70.00% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on QGEN. Bank of America boosted their target price on Qiagen from $50.00 to $53.00 and gave the stock a "buy" rating in a research report on Thursday, June 26th. Wall Street Zen downgraded Qiagen from a "strong-buy" rating to a "buy" rating in a research report on Monday, August 11th. UBS Group boosted their target price on Qiagen from $48.00 to $50.00 and gave the stock a "neutral" rating in a research report on Thursday, August 7th. Cowen reiterated a "hold" rating on shares of Qiagen in a research report on Thursday, August 7th. Finally, Barclays began coverage on Qiagen in a research report on Tuesday, June 24th. They issued an "overweight" rating and a $55.00 price objective for the company. Three analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company. According to data from MarketBeat.com, the company has an average rating of "Hold" and an average price target of $49.69.

Qiagen Stock Up 1.5%

Shares of NYSE:QGEN traded up $0.7430 during midday trading on Friday, reaching $49.8730. The company's stock had a trading volume of 210,226 shares, compared to its average volume of 1,366,186. Qiagen N.V. has a 12-month low of $37.63 and a 12-month high of $51.88. The firm has a market capitalization of $11.09 billion, a P/E ratio of 29.52, a PEG ratio of 2.58 and a beta of 0.64. The firm has a 50 day moving average of $48.56 and a 200-day moving average of $43.85. The company has a quick ratio of 1.35, a current ratio of 1.61 and a debt-to-equity ratio of 0.25.

Qiagen (NYSE:QGEN - Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported $0.60 EPS for the quarter, hitting analysts' consensus estimates of $0.60. Qiagen had a return on equity of 14.77% and a net margin of 18.30%.The firm had revenue of $533.54 million for the quarter, compared to analysts' expectations of $523.97 million. During the same period in the prior year, the firm posted $0.55 earnings per share. The company's quarterly revenue was up 7.7% on a year-over-year basis. Qiagen has set its Q3 2025 guidance at 0.580- EPS. FY 2025 guidance at 2.350-2.350 EPS. On average, research analysts anticipate that Qiagen N.V. will post 2.26 earnings per share for the current year.

Qiagen Dividend Announcement

The company also recently announced a dividend, which was paid on Thursday, July 10th. Shareholders of record on Thursday, July 3rd were given a $0.25 dividend. This represents a yield of 52.0%. The ex-dividend date of this dividend was Wednesday, July 2nd. Qiagen's dividend payout ratio (DPR) is presently 14.79%.

Qiagen Profile

QIAGEN NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials.